Carglumic Acid-impurities | Pharmaffiliates

carglumic acid

Carglumic acid is used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. It is an orphan drug, marketed by Orphan Europe under the trade name Carbaglu. Reference standards of Carglumic Acid API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => N-Carbamyl-L-glutamic Acid-d5
    [catalogue_number] => PA STI 017520
    [category_ids] => ,97,78,70,82,98,
    [chemical_name] => 
    [weight] => 195.18
    [form] => C6H5D5N2O5
    [cas] => NA
    [pslug] => n-carbamyl-l-glutamic-acid-d5-pasti017520
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 017520

N-Carbamyl-L-glutamic Acid-d5


  • Catalogue No.:PA STI 017520

  • CAS :

    NA

  • Molecular Formula : C6H5D5N2O5

  • Molecular Weight : 195.18